Travere Therapeutics (TVTX) Capital Expenditures Growth (1y) (2014 - 2024)
Travere Therapeutics (TVTX) Capital Expenditures Growth (1y) (2014 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Travere Therapeutics |
5.07 Bn |
4.99 Bn |
102.38 Mn |
- |
| Date | Value |
|---|
| Jun 30, 2024 |
2,633.33% |
| Dec 31, 2023 |
-16.67% |
| Sep 30, 2023 |
-23.08% |
| Jun 30, 2023 |
-82.35% |
| Mar 31, 2023 |
380.92% |
| Dec 31, 2022 |
-80.52% |
| Sep 30, 2022 |
-96.28% |
| Jun 30, 2022 |
-83.50% |
| Mar 31, 2022 |
-97.09% |
| Dec 31, 2021 |
115.01% |
| Sep 30, 2021 |
-85.51% |
| Jun 30, 2021 |
-66.77% |
| Mar 31, 2021 |
2,061.06% |
| Dec 31, 2020 |
-1,027.47% |
| Sep 30, 2020 |
808.68% |
| Jun 30, 2020 |
15,400.00% |
| Mar 31, 2020 |
994.74% |
| Dec 31, 2019 |
87.48% |
| Sep 30, 2019 |
110.32% |
| Jun 30, 2019 |
-99.64% |
